Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dapagliflozin (farxiga) (1 trial)
Ocedurenone (1 trial)
sacubitril (Entresto) (1 trial)
valsartan (diovan) (1 trial)
atorvastatin (lipitor) (1 trial)
pitavastatin (livalo) (1 trial)
onabotulinumtoxinA (Botox) (1 trial)
vigiis 101-lab (1 trial)
Heart Failure (Phase 4)
Hypercholesterolemia (Phase 3)
Hypotension (Phase 4)
Stroke (Phase 2)
Trials (4 total)
Trial APIs (8 total)